Elevated Cortisol at Retrieval Suppresses False Memories in Parallel with Correct Memories

2011 ◽  
Vol 23 (4) ◽  
pp. 772-781 ◽  
Author(s):  
Susanne Diekelmann ◽  
Ines Wilhelm ◽  
Ullrich Wagner ◽  
Jan Born

Retrieving a memory is a reconstructive process in which encoded representations can be changed and distorted. This process sometimes leads to the generation of “false memories,” that is, when people remember events that, in fact, never happened. Such false memories typically represent a kind of “gist” being extracted from single encountered events. The stress hormone cortisol is known to substantially impair memory retrieval. Here, in a double-blind, placebo-controlled crossover design, we tested the effect of an intravenous cortisol infusion before retrieval testing on the occurrence of false memories and on recall of correct memories using a modified Deese–Roediger–McDermott paradigm. Subjects studied sets of abstract shapes, with each set being derived from one prototype that was not presented during learning. At retrieval taking place 9 hr after learning, subjects were presented with studied shapes, nonstudied shapes, and the prototypes, and had to indicate whether or not each shape had been presented at learning. Cortisol administration distinctly reduced susceptibility to false memories (i.e., false recognition of prototypes) and, in parallel, impaired retrieval of correct memories (i.e., correct recognition of studied shapes). Response bias as well as confidence ratings and remember/know/guess judgments were not affected. Our results support gist-based theories of false memory generation, assuming a simultaneous storage of the gist and specific details of an event. Cortisol, by a general impairing influence on retrieval operations, decreases, in parallel, retrieval of false (i.e., gist) and correct (i.e., specific) memories for the event.

Author(s):  
Māris Bukovskis ◽  
Madara Tirzīte ◽  
Gunta Strazda ◽  
Normunds Jurka ◽  
Renāte Ligere ◽  
...  

H1-antihistamines suppress wheal-and-flare reaction and skin blood perfusion measured by Laser Dopppler flowmetry: randomized, double-blind, placebo-controlled, crossover design study The aim of our study was to compare the influence of pre-treatment with H1-antihistamines (levocetirizine, desloratadine, clemastine, quifenadine, and sequifenadine) and a placebo on the histamine-induced weal and flare reaction, increase of skin blood perfusion and sedation. Thirty healthy volunteers were enrolled in the study. The study design was a prospective, randomised, double-blind, placebo-controlled, crossover, balanced clinical trial. Volunteers in randomised and double-blind order were treated with oral levocetirizine 5 mg, desloratadine 5 mg, clemastine 1 mg, quifenadine 50 mg, sequifenadine 50 mg or a placebo. Two hours after intake of medication, the histamine skin prick test was performed and skin blood perfusion was registered with further evaluation of sedative effect. We conclude that levocetirizine induced a significant and pronounced decrease of weal and flare reaction and skin blood perfusion compared to the placebo and the other H1-antihistamines. The effect of quifenadine and sequifenadine on weal reaction area was similar to desloratadine and clemastine. Regarding the sedative effect, we can conclude that second generation antihistamines appear to be not non-sedative but the least impairing, and the first generation antihistamines appear to be the most impairing on central nervous system function. There is a necessity to consider the sedating potential of antihistamines, along with other factors such as efficacy, when prescribing antihistamines to patients.


2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Tatsuhiro Ayabe ◽  
Masahiro Kita ◽  
Kuniaki Obara ◽  
Sumio Kondo ◽  
Satoshi Umeda ◽  
...  

IntroductionWith rapid increase of aging worldwide, the number of people suffering from cognitive decline and dementia has been rapidly increasing. Numerous epidemiological and clinical studies have shown that consumption of dairy products have beneficial effects on cognitive decline and dementia in elderly. Our previous demonstration using pharmacologically-induced amnesia model mice identified tryptophan-tyrosine-related peptides, especially glycine-threonine-tryptophan-tyrosine (GTWY) of lactotetrapeptide, b-lactolin, as responsible agents improving cognitive decline in whey digestions, and we have originally developed GTWY-rich whey peptide by a specific enzymatic digestion. However, the effect of GTWY-rich whey peptide on cognitive functions in human has not been investigated. The present study is the first clinical trial evaluating the effects of GTWY-rich whey peptide on cognitive functions in a randomized, double-blind, placebo-controlled design.MethodsHealthy middle to older adults, aged from 45 to 64 years, with a self-awareness of cognitive decline were recruited. 101 eligible subjects received either whey peptide tablets containing 1 g of the GTWY-rich whey peptide per day, which included 1.6 mg of GTWY, (N = 50) or placebo containing the same amount of maltodextrin (N = 51) for 12 weeks. Changes of cognitive functions from 0 week of the intervention were assessed using neuropsychological tests assessing memory functions (word recall, story recall and verbal fluency test) and attention and executive functions (stroop test, digit span, and paced auditory serial addition test) at 6 and 12 weeks.ResultsThe change of verbal fluency test (VFT) score evaluating long-term memory retrieval at 12 weeks in whey peptide group tended to be higher than that in placebo group. Subgroup analysis showed that in the subjects with high-level of subjective fatigue measured by visual-analog scale, the changes of VFT, stroop test evaluating inhibition of executive functions and subjective memory function test at 6 weeks in whey peptide group were significantly higher than those in placebo group. The change of VFT score was also significantly higher in subjects with high fatigue measured by profile of mood status.Discussion and ConclusionsThe present study suggests that consumption of GTWY-rich whey peptide improve cognitive functions, especially memory retrieval and executive function, in healthy middle to older adults, with high subjective fatigue. It is also suggested that prefrontal cortex functions, especially dorsolateral prefrontal cortex is associated with the effects of the whey peptide. Consumptions of 1 g GTWY-rich whey peptide in daily life are safe and easy, which might be a practical approach to support cognitive function.


2021 ◽  
Author(s):  
Goutam Mondal ◽  
Yan-Hong Wang ◽  
Matthew Butawan ◽  
Richard J Bloomer ◽  
Ryan Yates

Methylliberine and theacrine are methylurates found in the leaves of various Coffea species and Camellia assamica var. kucha, respectively. We previously demonstrated that the methylxanthine caffeine increased theacrine oral bioavailability in humans. Consequently, we conducted a double-blind, placebo-controlled study pharmacokinetic study in humans administered methylliberine, theacrine, and caffeine to determine methylliberine pharmacokinetic interaction potential with either caffeine or theacrine. Subjects (n = 12) received an oral dose of either methylliberine (25 or 100 mg), caffeine (150 mg), methylliberine (100 mg) plus caffeine (150 mg), or methylliberine (100 mg) plus theacrine (50 mg) using a randomized, double-blind, crossover design. Blood samples were collected over 24 hours and analyzed for methylliberine, theacrine, and caffeine using UPLC-MS/MS. Methylliberine exhibited linear pharmacokinetics that were unaffected by co-administration of either caffeine or theacrine. However, methylliberine co-administration resulted in decreased oral clearance (41.9 +/- 19.5 vs. 17.1 +/- 7.80 L/hr) and increased half-life (7.2 +/- 5.6 versus 15 +/- 5.8 hrs) of caffeine. Methylliberine had no impact on caffeine maximum concentration (440 +/- 140 vs. 458 +/- 93.5 ng/mL) or oral volume of distribution (351 +/- 148 vs. 316 +/- 76.4 L). We previously demonstrated theacrine bioavailability was enhanced by caffeine, however, caffeine pharmacokinetics were unaffected by theacrine. Herein, we found that methylliberine altered caffeine pharmacokinetics without a reciprocal interaction, which suggests caffeine may interact uniquely with different methylurates. Understanding the mechanism(s) of interaction between methylxanthines and methylurates is of critical importance in light of the recent advent of dietary supplements containing both purine alkaloid classes.


Nutrients ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 2254
Author(s):  
Philippa A. Jackson ◽  
Emma L. Wightman ◽  
Rachel Veasey ◽  
Joanne Forster ◽  
Julie Khan ◽  
...  

Background: In whole foods, polyphenols exist alongside a wide array of other potentially bioactive phytochemicals. Yet, investigations of the effects of combinations of polyphenols with other phytochemicals are limited. Objective: The current study investigated the effects of combining extracts of beetroot, ginseng and sage with phenolic-rich apple, blueberry and coffee berry extracts. Design: This randomized, double-blind, placebo-controlled crossover design investigated three active beverages in 32 healthy adults aged 18–49 years. Each investigational beverage comprised extracts of beetroot, ginseng and sage. Each also contained a phenolic-rich extract derived from apple (containing 234 mg flavanols), blueberry (300 mg anthocyanins) or coffee berry (440 mg chlorogenic acid). Cognition, mood and CBF parameters were assessed at baseline and then again at 60, 180 and 360 min post-drink. Results: Robust effects on mood and CBF were seen for the apple and coffee berry beverages, with increased subjective energetic arousal and hemodynamic responses being observed. Fewer effects were seen with the blueberry extract beverage. Conclusions: Either the combination of beetroot, ginseng and sage was enhanced by the synergistic addition of the apple and coffee berry extract (and to a lesser extent the blueberry extract) or the former two phenolic-rich extracts were capable of evincing the robust mood and CBF effects alone.


1998 ◽  
Vol 87 (04) ◽  
pp. 181-189 ◽  
Author(s):  
Dick Koster ◽  
Robbert Van Haselen ◽  
Gerard Jansen ◽  
Martin Dicke

AbstractAn homoeopathic pathogenic trial (HPT, proving) was carried out using a double-blind, placebo-controlled crossover method. The name of the medicine was also unknown to the volunteers. A number of subjects withdrew at the last minute, leading to an unbalanced randomisation. A strong period effect was observed, which makes results difficult to interpret. Most subjects were able to guess correctly which treatment was active and which placebo.


Sign in / Sign up

Export Citation Format

Share Document